New View Surgical, Inc. Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo

Hand-picked by hundreds of attending angel investors as a stand-out innovator amongst group of highly touted, growth-stage entrepreneurial companies from U.S. and Canada

SEATTLE, WA—New View Surgical, Inc. an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding. Nearly 50 angel groups, investors from 100+ Family Offices, corporate partners, and hundreds of accredited investors have attended the first two sessions of the Expo.

The Investor Capital Expo is hosted by Keiretsu Forum, the world’s largest angel investor network ranked by Pitchbook #1 in two categories: “Most active investors early stage” and “Most active investors late stage.”

New View Surgical was hand-picked by hundreds of attending angel investors as a stand-out innovator amongst a group of highly touted, entrepreneurial companies from U.S. and Canada. The final Investor Capital Expo Session 3 is on November 11th.

"We are very pleased to have been selected as a Most Valued Company by this experienced and active group of early stage investors," said Bryce Klontz, President & Chief Executive Officer at New View Surgical. “We appreciate the support of the Keiretsu Forum members and congratulate everyone involved with the Investor Capital Expo. Nearing the completion of a Series A-1 financing, New View Surgical is leveraging investor capital to bring our VisionPort System surgical technology to market. Our novel VisionPort System supports our overall mission to decrease cost, improve surgical imaging and increase access to minimally invasive surgical procedures for patients around the world.”

New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort™ System, a novel surgical imaging and access system for minimally invasive surgery. VisionPort™ combines multiple imaging and access devices into just one simple, easy-to-use device that is disposable and is expected to bring a variety of clinical and economic advantages to minimally invasive surgery operating rooms around the world. For more information please visit www.newviewsurg.com or follow the company on Twitter at @NewViewSurg.

Keiretsu Forum also named Caleb Carr, CEO of Vita Inclinata Technologies, as its “Entrepreneur of the Year” award; and also named member Arthur Goldman as its “Most Valued Investor” award winner.

About Keiretsu Forum

Keiretsu Forum is a global investment community of accredited private equity angel investors, venture capitalists and corporate/institutional investors. Keiretsu Forum was founded in 2000 by Randy Williams. Keiretsu Forum today is a worldwide network of capital, resources and deal flow with over 50 chapters on three continents. Keiretsu Forum members invest in high-quality, diverse investment opportunities. The community is strengthened through its involvement in social and charitable activities.